Association Between Serum Free Thyroxine Concentration and Atrial Fibrillation | Atrial Fibrillation | JAMA Internal Medicine | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.170.64.36. Please contact the publisher to request reinstatement.
1.
Tunbridge  WMEvered  DCHall  R  et al.  The spectrum of thyroid disease in a community: the Whickham survey.  Clin Endocrinol (Oxf) 1977;7481- 493PubMedGoogle ScholarCrossref
2.
Canaris  GJManowitz  NRMayor  GRidgway  EC The Colorado thyroid disease prevalence study.  Arch Intern Med 2000;160526- 534PubMedGoogle ScholarCrossref
3.
Hollowell  JGStaehling  NWFlanders  WD  et al.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).  J Clin Endocrinol Metab 2002;87489- 499PubMedGoogle ScholarCrossref
4.
Parle  JVFranklyn  JACross  KWJones  SCSheppard  MC Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom.  Clin Endocrinol (Oxf) 1991;3477- 83PubMedGoogle ScholarCrossref
5.
Biondi  BPalmieri  EAFazio  S  et al.  Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients.  J Clin Endocrinol Metab 2000;854701- 4705PubMedGoogle Scholar
6.
Cappola  ARFried  LPArnold  AM  et al.  Thyroid status, cardiovascular risk, and mortality in older adults.  JAMA 2006;2951033- 1041PubMedGoogle ScholarCrossref
7.
Sawin  CTGeller  AWolf  PA  et al.  Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons.  N Engl J Med 1994;3311249- 1252PubMedGoogle ScholarCrossref
8.
Auer  JScheibner  PMische  TLangsteger  WEber  OEber  B Subclinical hyperthyroidism as a risk factor for atrial fibrillation.  Am Heart J 2001;142838- 842PubMedGoogle ScholarCrossref
9.
Wolf  PAAbbott  RDKannel  WB Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.  Stroke 1991;22983- 988PubMedGoogle ScholarCrossref
10.
Parle  JVMaisonneuve  PSheppard  MCBoyle  PFranklyn  JA Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study.  Lancet 2001;358861- 865PubMedGoogle ScholarCrossref
11.
Biondi  BPalmieri  EALombardi  GFazio  S Subclinical hypothyroidism and cardiac function.  Thyroid 2002;12505- 510PubMedGoogle ScholarCrossref
12.
Danese  MDLadenson  PWMeinert  CLPowe  NR Clinical review 115: effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature.  J Clin Endocrinol Metab 2000;852993- 3001PubMedGoogle Scholar
13.
Ripoli  APingitore  AFavilli  B  et al.  Does subclinical hypothyroidism affect cardiac pump performance? evidence from a magnetic resonance imaging study.  J Am Coll Cardiol 2005;45439- 445PubMedGoogle ScholarCrossref
14.
Gussekloo  Jvan Exel  Ede Craen  AJMeinders  AEFrolich  MWestendorp  RG Thyroid status, disability and cognitive function, and survival in old age.  JAMA 2004;2922591- 2599PubMedGoogle ScholarCrossref
15.
Hak  AEPols  HAVisser  TJDrexhage  HAHofman  AWitteman  JC Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study.  Ann Intern Med 2000;132270- 278PubMedGoogle ScholarCrossref
16.
Lindeman  RDRomero  LJSchade  DSWayne  SBaumgartner  RNGarry  PJ Impact of subclinical hypothyroidism on serum total homocysteine concentrations, the prevalence of coronary heart disease (CHD), and CHD risk factors in the New Mexico Elder Health Survey.  Thyroid 2003;13595- 600PubMedGoogle ScholarCrossref
17.
Rodondi  NNewman  ABVittinghoff  E  et al.  Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death.  Arch Intern Med 2005;1652460- 2466PubMedGoogle ScholarCrossref
18.
Vanderpump  MPTunbridge  WMFrench  JM  et al.  The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community.  Thyroid 1996;6155- 160PubMedGoogle Scholar
19.
Walsh  JPBremner  APBulsara  MK  et al.  Subclinical thyroid dysfunction as a risk factor for cardiovascular disease.  Arch Intern Med 2005;1652467- 2472PubMedGoogle ScholarCrossref
20.
Rodondi  NAujesky  DVittinghoff  ECornuz  JBauer  DC Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis.  Am J Med 2006;119541- 551PubMedGoogle ScholarCrossref
21.
Surks  MIOrtiz  EDaniels  GH  et al.  Subclinical thyroid disease: scientific review and guidelines for diagnosis and management.  JAMA 2004;291228- 238PubMedGoogle ScholarCrossref
22.
Wilson  SParle  JVRoberts  LM  et al.  Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community based cross-sectional survey.  J Clin Endocrinol Metab 2006;914809- 4816PubMedGoogle ScholarCrossref
23.
Jick  HJick  SSDerby  LE Validation of information recorded on general practitioner based computerised data resource in the United Kingdom.  BMJ 1991;302766- 768PubMedGoogle ScholarCrossref
24.
Jick  SSKaye  JAVasilakis-Scaramozza  C  et al.  Validity of the general practice research database.  Pharmacotherapy 2003;23686- 689PubMedGoogle ScholarCrossref
25.
Boelaert  KHoracek  JHolder  RLWatkinson  JCSheppard  MCFranklyn  JA Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration.  J Clin Endocrinol Metab 2006;914295- 4301PubMedGoogle ScholarCrossref
26.
Klein  IOjamaa  K Thyroid hormone and the cardiovascular system.  N Engl J Med 2001;344501- 509PubMedGoogle ScholarCrossref
27.
Basaria  SCooper  DS Amiodarone and the thyroid.  Am J Med 2005;118706- 714PubMedGoogle ScholarCrossref
28.
Peters  NSSchilling  RJKanagaratnam  PMarkides  V Atrial fibrillation: strategies to control, combat, and cure.  Lancet 2002;359593- 603PubMedGoogle ScholarCrossref
29.
Heeringa  Jvan der Kuip  DAHofman  A  et al.  Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study.  Eur Heart J 2006;27949- 953PubMedGoogle ScholarCrossref
30.
Langenberg  MHellemons  BSvan Ree  JW  et al.  Atrial fibrillation in elderly patients: prevalence and comorbidity in general practice.  BMJ 1996;3131534PubMedGoogle ScholarCrossref
31.
Phillips  SJWhisnant  JPO'Fallon  WMFrye  RL Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota.  Mayo Clin Proc 1990;65344- 359PubMedGoogle ScholarCrossref
32.
Wolf  PAD'Agostino  RB Secular trends in stroke in the Framingham Study.  Ann Epidemiol 1993;3471- 475PubMedGoogle ScholarCrossref
33.
Frost  LVestergaard  PMosekilde  L Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study.  Arch Intern Med 2004;1641675- 1678PubMedGoogle ScholarCrossref
34.
Petersen  PHansen  JM Stroke in thyrotoxicosis with atrial fibrillation.  Stroke 1988;1915- 18PubMedGoogle ScholarCrossref
35.
Sandler  GWilson  GM The nature and prognosis of heart disease in thyrotoxicosis: a review of 150 patients treated with 131 I.  Q J Med 1959;28347- 369PubMedGoogle Scholar
36.
Bar-Sela  SEhrenfeld  MEliakim  M Arterial embolism in thyrotoxicosis with atrial fibrillation.  Arch Intern Med 1981;1411191- 1192PubMedGoogle ScholarCrossref
37.
Surks  MISievert  R Drugs and thyroid function.  N Engl J Med 1995;3331688- 1694PubMedGoogle ScholarCrossref
38.
Fazio  SPalmieri  EALombardi  GBiondi  B Effects of thyroid hormone on the cardiovascular system.  Recent Prog Horm Res 2004;5931- 50PubMedGoogle ScholarCrossref
39.
Chen  YCChen  SAChen  YJChang  MSChan  PLin  CI Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes.  J Am Coll Cardiol 2002;39366- 372PubMedGoogle ScholarCrossref
40.
Sgarbi  JAVillaca  FGGarbeline  BVillar  HERomaldini  JH The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities.  J Clin Endocrinol Metab 2003;881672- 1677PubMedGoogle ScholarCrossref
41.
van den Beld  AWVisser  TJFeelders  RAGrobbee  DELamberts  SW Thyroid hormone concentrations, disease, physical function, and mortality in elderly men.  J Clin Endocrinol Metab 2005;906403- 6409PubMedGoogle ScholarCrossref
Original Investigation
May 14, 2007

Association Between Serum Free Thyroxine Concentration and Atrial Fibrillation

Author Affiliations

Author Affiliations: Departments of Cardiovascular Medicine (Dr Gammage) and Medicine (Drs Sheppard and Franklyn), Division of Medical Sciences and Department of General Practice (Drs Parle, Roberts, Hobbs, and Wilson and Mr Holder), Division of Primary Care, Public, and Occupational Health, University of Birmingham, Birmingham, England.

Arch Intern Med. 2007;167(9):928-934. doi:10.1001/archinte.167.9.928
Abstract

Background  Previous studies have suggested that minor changes in thyroid function are associated with risk of atrial fibrillation (AF). Our objective was to determine the relationship between thyroid function and presence of atrial fibrillation (AF) in older subjects.

Methods  A population-based study of 5860 subjects 65 years and older, which excluded those being treated for thyroid dysfunction and those with previous hyperthyroidism. Main outcome measures included tests of thyroid function (serum free thyroxine [T4] and thyrotropin [TSH]) and the presence of AF on resting electrocardiogram.

Results  Fourteen subjects (0.2%) had previously undiagnosed overt hyperthyroidism and 126 (2.2%), subclinical hyperthyroidism; 5519 (94.4%) were euthyroid; and 167 (2.9%) had subclinical hypothyroidism and 23 (0.4%), overt hypothyroidism. The prevalence of AF in the whole cohort was 6.6% in men and 3.1% in women (odds ratio, 2.23; P<.001). After adjusting for sex, logistic regression showed a higher prevalence of AF in those with subclinical hyperthyroidism compared with euthyroid subjects (9.5% vs 4.7%; adjusted odds ratio, 2.27; P = .01). Median serum free T4 concentration was higher in those with AF than in those without (1.14 ng/dL; interquartile range [IQR], 1.05-1.27 ng/dL [14.7 pmol/L; IQR, 13.5-16.4 pmol/L] vs 1.10 ng/dL; IQR, 1.00-1.22 ng/dL [14.2 pmol/L; IQR, 12.9-15.7 pmol/L]; P<.001), and higher in those with AF when analysis was limited to euthyroid subjects (1.13 ng/dL; IQR, 1.05-1.26 ng/dL [14.6 pmol/L; IQR, 13.5-16.2 pmol/L] vs 1.10 ng/dL; IQR, 1.01-1.21 ng/dL [14.2 pmol/L; IQR, 13.0-15.6 pmol/L]; P = .001). Logistic regression showed serum free T4 concentration, increasing category of age, and male sex all to be independently associated with AF. Similar independent associations were observed when analysis was confined to euthyroid subjects with normal TSH values.

Conclusions  The biochemical finding of subclinical hyperthyroidism is associated with AF on resting electrocardiogram. Even in euthyroid subjects with normal serum TSH levels, serum free T4 concentration is independently associated with AF.

×